 "indian firms, economy")
Pathogens becoming immune to antibiotics, why India should make life easy for smaller firms, and what global central banks are doing and what India’s central bank is likely to do -- for today
How a health crisis is in the offing owing to antimicrobial resistance. Sunita Narain gives all its aspects.
Ajay Shah lays down the road for weaker firms to stay in business.
Tamal Bandyopadhyay: Expect status quo on rate and no change in stance (on the credit policy this week).
The first edit says the period until the Lok Sabha elections will be volatile for stocks. The second edit gives the reasons why regulating unlisted firms must not lose sight of ease of doing business.
